NVDA
NVIDIA Corporation
NVDA has the edge over RSKD overall, supported by stronger valuation and stronger modeled upside.
RSKD
Riskified Ltd.
RSKD's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
RSKD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
RSKD's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
RSKD PE Valuation
RSKD has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
RSKD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RSKD has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over RSKD on earnings quality, reporting a profit while its opponent remains loss making.
RSKD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.38 | — |
| Q2 2026 | -$0.11 | +$0.13 |
| Q1 2026 | -$0.12 | +$0.10 |
| Q4 2025 | -$0.17 | +$0.03 |
| Q3 2025 | -$0.23 | -$0.03 |
| Q2 2025 | -$0.24 | +$0.02 |
| Q1 2025 | -$0.22 | +$0.08 |
| Q4 2024 | -$0.20 | +$0.13 |
| Q3 2024 | -$0.20 | +$0.19 |
RSKD is still losing money, but far less than before: $0.11 per share over the past year, against $1.33 at its worst in late 2021.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over RSKD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over RSKD on profitability, with a higher operating margin.
RSKD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $98.7M | +22% |
| Q1 2026 | $88.3M | +7.1% |
| Q4 2025 | $99.3M | +6.2% |
| Q3 2025 | $81.9M | +3.8% |
| Q2 2025 | $81.1M | +3% |
| Q1 2025 | $82.4M | +7.8% |
| Q4 2024 | $93.5M | +11% |
| Q3 2024 | $78.8M | +9.7% |
RSKD's revenue has grown year over year every quarter since early 2021: $99M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -7.5% | +8.5 points |
| Q1 2026 | -6.7% | +14 points |
| Q4 2025 | 5.3% | +8.9 points |
| Q3 2025 | -11% | +7.2 points |
| Q2 2025 | -16% | +2 points |
| Q1 2025 | -21% | +0.1 points |
| Q4 2024 | -3.6% | +4.2 points |
| Q3 2024 | -18% | +17 points |
RSKD's operating margin was −7.5% last quarter, up 8.5 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over RSKD on cash flow, with more consistent year-over-year improvement.
RSKD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $13.1M | +146% |
| Q1 2026 | $9.4M | +158% |
| Q4 2025 | $11.7M | +11% |
| Q3 2025 | $13.4M | -3.8% |
| Q2 2025 | $5.3M | +30% |
| Q1 2025 | $3.6M | -65% |
| Q4 2024 | $10.6M | +48% |
| Q3 2024 | $13.9M | +279% |
RSKD generated $48M in free cash flow over the past year, up 42% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
RSKD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.5% | -8.1M shares |
| 1 year | -12% | -19.8M shares |
| 3 years | -21% | -36.3M shares |
| 5 years | -12% | -18.2M shares |
| Available history | -12% | -18.3M shares |
RSKD has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $66M |
| Q1 2026 | $27.6M |
| Q4 2025 | $40.3M |
| Q3 2025 | $25.3M |
| Q2 2025 | $23.3M |
| Q1 2025 | $20.7M |
| Q4 2024 | $24.6M |
| Q3 2024 | $47M |
RSKD spent $159M buying back its own shares over the past year, up 38% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
RSKD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -38.4x | Net Cash |
RSKD has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
RSKD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.4 | Overbought |
| Stochastic | 79.4 | Neutral |
RSKD's weekly RSI is 74 (overbought) and its Stochastic is 79 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
RSKD PE vs Technology Sector
RSKD has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
RSKD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.51 | 11% above |
| 20 week MA | $6.83 | 38% above |
| 50 week MA | $5.48 | 72% above |
| 100 week MA | $5.17 | 82% above |
| 200 week MA | $5.08 | 85% above |
RSKD has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
RSKD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $27.4 | $8.00 | -71% |
| 2022 | $8.00 | $4.72 | -41% |
| 2023 | $4.72 | $4.68 | -0.8% |
| 2024 | $4.68 | $4.75 | +1.5% |
| 2025 | $4.75 | $5.01 | +5.5% |
| 2026 YTD | $5.01 | $9.42 | +88% |
RSKD has the edge over NVDA on returns for 2026, with the stronger performance.